tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Cautious Hold on Alector Amid Strategic Shift and Long-term Focus
PremiumRatingsCautious Hold on Alector Amid Strategic Shift and Long-term Focus
27d ago
Alector reports Q3 EPS (34c), consensus (41c)
Premium
The Fly
Alector reports Q3 EPS (34c), consensus (41c)
27d ago
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment
Premium
Company Announcements
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment
1M ago
Alector downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe FlyAlector downgraded to Neutral from Overweight at Cantor Fitzgerald
1M ago
Alector downgraded to Neutral from Outperform at Mizuho
Premium
The Fly
Alector downgraded to Neutral from Outperform at Mizuho
1M ago
Alector downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Alector downgraded to Hold from Buy at TD Cowen
1M ago
Alector trading halted, news pending
PremiumThe FlyAlector trading halted, news pending
1M ago
Alector’s Promising Biotech Position: Buy Rating Backed by Upcoming INFRONT-3 Trial and Diversified Pipeline
Premium
Ratings
Alector’s Promising Biotech Position: Buy Rating Backed by Upcoming INFRONT-3 Trial and Diversified Pipeline
2M ago
Alector’s Strategic Positioning and Innovative Approach in Neuroscience Earns Buy Rating
Premium
Ratings
Alector’s Strategic Positioning and Innovative Approach in Neuroscience Earns Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100